Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M F Powell

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Analytical Chemistry|October 24, 1997
Formulation development and primary degradation pathways for recombinant human nerve growth factorM Eng, V Ling, J A Briggs, et al.
International Journal of Obstetric Anesthesia|October 30, 2020
General anesthesia for cesarean delivery and childhood neurodevelopmental and perinatal outcomes: a secondary analysis of a randomized controlled trialL S Robbins, C T Blanchard, F J Biasini, et al.
Journal of Pharmaceutical Sciences|December 1, 1996
Development of a single-shot subunit vaccine for HIV-1. 2. Defining optimal autoboost characteristics to maximize the humoral immune responseJ L Cleland, L Barrón, P W Berman, et al.
Clinical Pharmacy|September 1, 1983
Evaluation of a method for intravenous phenytoin infusionS C Boike, M J Rybak, J E Tintinalli, et al.
Journal of Pharmaceutical Sciences|December 1, 1996
Development of a single-shot subunit vaccine for HIV-1. 3. Effect of adjuvant and immunization schedule on the duration of the humoral immune response to recombinant MN gp120J L Cleland, L Barrón, A Daugherty, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1994
Failure to demonstrate long-lived MHC saturation both in vitro and in vivo. Implications for therapeutic potential of MHC-blocking peptidesG Y Ishioka, L Adorini, J C Guery, et al.
Pharmaceutical Research|September 1, 1993
Peptide stability in drug development. II. Effect of single amino acid substitution and glycosylation on peptide reactivity in human serumM F Powell, T Stewart, L Otvos, et al.
Vaccine|June 1, 1997
Induction of cross-reactive cytotoxic T-lymphocyte responses specific for HIV-1 gp120 using saponin adjuvant (QS-21) supplemented subunit vaccine formulationsM J Newman, J Y Wu, B H Gardner, et al.
AIDS Research and Human Retroviruses|January 1, 1994
Development of a single-shot subunit vaccine for HIV-1J L Cleland, M F Powell, A Lim, et al.
Journal of Pharmaceutical Sciences|January 1, 1996
Isomerization and formulation stability of the vaccine adjuvant QS-21J L Cleland, C R Kensil, A Lim, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Analytical Chemistry|October 24, 1997
Formulation development and primary degradation pathways for recombinant human nerve growth factorM Eng, V Ling, J A Briggs, et al.
International Journal of Obstetric Anesthesia|October 30, 2020
General anesthesia for cesarean delivery and childhood neurodevelopmental and perinatal outcomes: a secondary analysis of a randomized controlled trialL S Robbins, C T Blanchard, F J Biasini, et al.
Journal of Pharmaceutical Sciences|December 1, 1996
Development of a single-shot subunit vaccine for HIV-1. 2. Defining optimal autoboost characteristics to maximize the humoral immune responseJ L Cleland, L Barrón, P W Berman, et al.
Clinical Pharmacy|September 1, 1983
Evaluation of a method for intravenous phenytoin infusionS C Boike, M J Rybak, J E Tintinalli, et al.
Journal of Pharmaceutical Sciences|December 1, 1996
Development of a single-shot subunit vaccine for HIV-1. 3. Effect of adjuvant and immunization schedule on the duration of the humoral immune response to recombinant MN gp120J L Cleland, L Barrón, A Daugherty, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1994
Failure to demonstrate long-lived MHC saturation both in vitro and in vivo. Implications for therapeutic potential of MHC-blocking peptidesG Y Ishioka, L Adorini, J C Guery, et al.
Pharmaceutical Research|September 1, 1993
Peptide stability in drug development. II. Effect of single amino acid substitution and glycosylation on peptide reactivity in human serumM F Powell, T Stewart, L Otvos, et al.
Vaccine|June 1, 1997
Induction of cross-reactive cytotoxic T-lymphocyte responses specific for HIV-1 gp120 using saponin adjuvant (QS-21) supplemented subunit vaccine formulationsM J Newman, J Y Wu, B H Gardner, et al.
AIDS Research and Human Retroviruses|January 1, 1994
Development of a single-shot subunit vaccine for HIV-1J L Cleland, M F Powell, A Lim, et al.
Journal of Pharmaceutical Sciences|January 1, 1996
Isomerization and formulation stability of the vaccine adjuvant QS-21J L Cleland, C R Kensil, A Lim, et al.
Pageof 6